SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-008245
Filing Date
2018-04-16
Accepted
2018-04-16 16:27:50
Documents
4
Period of Report
2018-05-04
Effectiveness Date
2018-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A insy-def14a_20171231.htm DEF 14A 1212387
2 GRAPHIC g2018041615542631713640.jpg GRAPHIC 75951
3 GRAPHIC g2018041615541705313638.jpg GRAPHIC 2183
4 GRAPHIC g2018041615542628713639.jpg GRAPHIC 105097
  Complete submission text file 0001564590-18-008245.txt   1466218
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35902 | Film No.: 18756896
SIC: 2834 Pharmaceutical Preparations